• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

干预治疗药物,理解 2 型糖尿病缓解的途径:第 1 部分。

Intervention with Therapeutic Agents, Understanding the Path to Remission in Type 2 Diabetes: Part 1.

机构信息

Division of Pediatric Endocrinology, Children's Healthcare of Atlanta, Emory University School of Medicine, 1400 Tullie Road Northeast, Atlanta, GA 30329, USA.

Division of Endocrinology, Metabolism & Lipids, Emory University School of Medicine, 69 Jesse Hill Jr Drive Southeast, Glenn Building, Room 205, Suite 200, Atlanta, GA 30303, USA.

出版信息

Endocrinol Metab Clin North Am. 2023 Mar;52(1):27-38. doi: 10.1016/j.ecl.2022.07.003. Epub 2022 Nov 14.

DOI:10.1016/j.ecl.2022.07.003
PMID:36754495
Abstract

Type 2 diabetes is characterized by progressive decline in pancreatic β-cell function. Studies in adult subjects with newly diagnosed type 2 diabetes have reported that intensive insulin therapy followed by various antihyperglycemic medications can delay β-cell decline. However, this improvement is lost after cessation of therapy. In contrast, youth with type 2 diabetes experience a more rapid loss in β-cell function compared with adults and have loss of β-cell function despite being on insulin and other antihyperglycemic medications. In part one of this two-part review, we discuss studies aiming to achieve diabetes remission with insulin and oral antidiabetic medications.

摘要

2 型糖尿病的特征是胰腺β细胞功能进行性下降。在新诊断为 2 型糖尿病的成年患者中进行的研究报告称,强化胰岛素治疗后使用各种降血糖药物可以延缓β细胞的下降。然而,停止治疗后这种改善就会消失。相比之下,与成年人相比,患有 2 型糖尿病的青少年β细胞功能丧失更快,尽管使用胰岛素和其他降血糖药物,β细胞功能仍会丧失。在这篇两部分综述的第一部分中,我们讨论了旨在通过胰岛素和口服降糖药物实现糖尿病缓解的研究。

相似文献

1
Intervention with Therapeutic Agents, Understanding the Path to Remission in Type 2 Diabetes: Part 1.干预治疗药物,理解 2 型糖尿病缓解的途径:第 1 部分。
Endocrinol Metab Clin North Am. 2023 Mar;52(1):27-38. doi: 10.1016/j.ecl.2022.07.003. Epub 2022 Nov 14.
2
Short-term intensive insulin therapy could be the preferred option for new onset Type 2 diabetes mellitus patients with HbA1c > 9.对于新诊断的糖化血红蛋白(HbA1c)>9%的 2 型糖尿病患者,短期强化胰岛素治疗可能是首选。
J Diabetes. 2017 Oct;9(10):890-893. doi: 10.1111/1753-0407.12581. Epub 2017 Aug 22.
3
Effect of intensive insulin therapy on beta-cell function and glycaemic control in patients with newly diagnosed type 2 diabetes: a multicentre randomised parallel-group trial.强化胰岛素治疗对新诊断2型糖尿病患者β细胞功能及血糖控制的影响:一项多中心随机平行组试验
Lancet. 2008 May 24;371(9626):1753-60. doi: 10.1016/S0140-6736(08)60762-X.
4
Current role of short-term intensive insulin strategies in newly diagnosed type 2 diabetes.新诊断 2 型糖尿病患者短期强化胰岛素治疗策略的现状。
J Diabetes. 2013 Sep;5(3):268-74. doi: 10.1111/1753-0407.12054. Epub 2013 May 29.
5
Long-term effects on glycaemic control and β-cell preservation of early intensive treatment in patients with newly diagnosed type 2 diabetes: A multicentre randomized trial.新诊断 2 型糖尿病患者早期强化治疗对血糖控制和β细胞保护的长期影响:一项多中心随机试验。
Diabetes Obes Metab. 2018 May;20(5):1121-1130. doi: 10.1111/dom.13196. Epub 2018 Jan 22.
6
Short-term intensive therapy in newly diagnosed type 2 diabetes partially restores both insulin sensitivity and β-cell function in subjects with long-term remission.新诊断 2 型糖尿病患者的短期强化治疗部分恢复了长期缓解患者的胰岛素敏感性和β细胞功能。
Diabetes Care. 2011 Aug;34(8):1848-53. doi: 10.2337/dc10-2105. Epub 2011 Jun 16.
7
Intervention with Therapeutic Agents, Understanding the Path to Remission to Type 2 Diabetes: Part 2.干预治疗药物,了解 2 型糖尿病缓解途径:第 2 部分。
Endocrinol Metab Clin North Am. 2023 Mar;52(1):39-47. doi: 10.1016/j.ecl.2022.07.004. Epub 2022 Nov 18.
8
Beta cell functionality and hepatic insulin resistance are major contributors to type 2 diabetes remission and starting pharmacological therapy: from CORDIOPREV randomized controlled trial.β细胞功能和肝胰岛素抵抗是 2 型糖尿病缓解和开始药物治疗的主要原因:来自 CORDIOPREV 随机对照试验。
Transl Res. 2021 Dec;238:12-24. doi: 10.1016/j.trsl.2021.07.001. Epub 2021 Jul 21.
9
Improved skeletal muscle energy metabolism relates to the recovery of β cell function by intensive insulin therapy in drug naïve type 2 diabetes.强化胰岛素治疗可改善骨骼肌能量代谢,从而恢复新诊断 2 型糖尿病患者的胰岛β细胞功能。
Diabetes Metab Res Rev. 2019 Oct;35(7):e3177. doi: 10.1002/dmrr.3177. Epub 2019 May 27.
10
The effect of early insulin therapy on pancreatic β-cell function and long-term glycemic control in newly diagnosed type 2 diabetic patients.新诊断 2 型糖尿病患者早期胰岛素治疗对胰岛β细胞功能和长期血糖控制的影响。
Korean J Intern Med. 2010 Sep;25(3):273-81. doi: 10.3904/kjim.2010.25.3.273. Epub 2010 Aug 31.

引用本文的文献

1
Construction and Implications of Nomogram for Predicting Sustained Glycemic Remission After Short-Term Intensive Insulin Therapy in Newly Diagnosed Type 2 Diabetes.新诊断2型糖尿病短期强化胰岛素治疗后持续血糖缓解预测列线图的构建及意义
J Diabetes. 2025 Aug;17(8):e70135. doi: 10.1111/1753-0407.70135.
2
Global research trends of diabetes remission: a bibliometric study.全球糖尿病缓解研究趋势:文献计量研究。
Front Endocrinol (Lausanne). 2023 Nov 28;14:1272651. doi: 10.3389/fendo.2023.1272651. eCollection 2023.
3
Promising improvement in infected Wound Healing in Type two Diabetic rats by Combined effects of conditioned medium of human adipose-derived stem cells plus Photobiomodulation.
人脂肪来源干细胞条件培养基联合光生物调节对2型糖尿病大鼠感染伤口愈合有显著改善作用。
Lab Anim Res. 2023 Nov 15;39(1):29. doi: 10.1186/s42826-023-00178-z.
4
Diabetic Ketoacidosis and Long-term Insulin Requirements in Youths with Newly Diagnosed Type 2 Diabetes During the SARS-CoV-2 Pandemic.新冠疫情期间新诊断为 2 型糖尿病的青少年中的糖尿病酮症酸中毒和长期胰岛素需求。
Endocr Pract. 2023 Oct;29(10):754-761. doi: 10.1016/j.eprac.2023.07.002. Epub 2023 Jul 13.